Michael Scott Salka
2016
In 2016, Michael Scott Salka earned a total compensation of $528K as Chief Executive Officer at AmpliPhi Biosciences, a 86% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $102,000 |
|---|---|
| Salary | $425,000 |
| Other | $988 |
| Total | $527,988 |
Salka received $425K in salary, accounting for 80% of the total pay in 2016.
Salka also received $102K in non-equity incentive plan and $988 in other compensation.
Rankings
In 2016, Michael Scott Salka's compensation ranked 10,977th out of 14,075 executives tracked by ExecPay. In other words, Salka earned more than 22.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 10,977 out of 14,075 | 22nd |
Division Manufacturing | 4,264 out of 5,486 | 22nd |
Major group Chemicals And Allied Products | 1,523 out of 1,900 | 20th |
Industry group Drugs | 1,227 out of 1,543 | 21st |
Industry Biological Products, Except Diagnostic Substances | 216 out of 287 | 25th |
Source: SEC filing on July 24, 2017.
Salka's colleagues
We found three more compensation records of executives who worked with Michael Scott Salka at AmpliPhi Biosciences in 2016.